Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The heat-labile enterotoxin B subunit (LTB) is a component of the heat-labile enterotoxin (LT) produced by Escherichia coli (ETEC). LTB is a pentamer that binds to GM1 gangliosides on host cell membranes, facilitating the entry of the toxic LT-A subunit into cells. While non-toxic on its own, LTB plays a crucial role in the pathogenesis of ETEC-related diarrheal disease. It also exhibits immunomodulatory properties.
Facilitates the entry of the Heat-labile enterotoxin A subunit into host cells by binding to GM1 gangliosides.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heat-labile enterotoxin B subunit (LTB).